Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-217873
Filing Date
2017-06-29
Accepted
2017-06-29 12:41:32
Documents
2
Effectiveness Date
2017-06-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d404112ddefa14a.htm DEFA14A 17187
2 GRAPHIC g404112img2.jpg GRAPHIC 9274
  Complete submission text file 0001193125-17-217873.txt   31325
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 17937554
SIC: 2834 Pharmaceutical Preparations